FMC Corporation will sell its Newark, Delaware property for $114 million and immediately lease back the Stine Research Center under a separate agreement. Proceeds will be applied to debt reduction while retaining full R&D operations at the global headquarters.
FMC entered into a framework agreement to sell its Newark, Delaware property for approximately $114 million, subject to due diligence and closing adjustments, and plans to lease back the Stine Research Center under a separate lease arrangement.
The company will continue operating its global R&D headquarters at the Stine Research Center and retain ownership of adjacent Maryland properties, ensuring uninterrupted research activities and infrastructure.
FMC intends to allocate the sale proceeds directly to debt reduction, reflecting its strategy to optimize the asset base and strengthen the balance sheet without compromising investment in core research capabilities.
The transaction is expected to close in the fourth quarter of 2026, contingent on the completion of due diligence, potential renegotiation of terms and satisfaction of customary closing conditions.
